Widening the Therapeutic Window of ADCs

Featured Speakers

  • Dennis BenjaminVP Seattle Genetics

  • Giulio CasiHead, ADCs Philochem

  • Palani PalaniappanVP & Global Head, CMC Takeda

  • Andreas PluckthunProfessor University of Zurich

World ADC Frankfurt has been established with the simple mission of speeding up the development of more potent and safe ADCs.

Learn not only how to make an ADC, but how to make a great one. With insights on numerous novel payload technologies, robust strategies for preclinical evaluation and emerging clinical data, there is no better opportunity to accelerate your research.

Having worked closely alongside the industry for the last five years, we have continually sought to spotlight the bravest and most innovative approaches to ADC optimisation. To benefit ADC programs like yours, we recognise the need to hear from those who have tried, failed and succeeded with their efforts.

More than 50 of Europe’s leading experts will be sharing valuable lessons learned and novel data at World ADC Frankfurt this year. From AstraZeneca, BMS and Concortis to Roche, Synthon and Takeda; there’s a multitude of different experiences to draw upon.

Download the brochure to see more

New for 2015:

  • A three stream format that will allow you to pick and choose the most relevant talks to your work from across discovery, development and CMC.
  • Clinical insights afternoon which will help you leverage your future ADC development.
  • A memorable networking evening that will give you the maximum opportunity to meet new colleagues and catch up with old friends. 

Check out the agenda to see all the talks that are scheduled.

Five talks that are not to be missed:

  1. Pfizer’s Puja Sapra will be giving a keynote lecture on the advances they have made with their latest conjugates for recently begun clinical trials
  2. Michel Eppink from Synthon will discuss purification and scale challenges for duocarmycin based ADCs
  3. Spirogen’s Philip Howard will discuss the latest optimisation of the PBD warheads which is enhancing efficacy and tolerability
  4. Antoine Deslandes will share Sanofi’s translational strategy for ADCs selected for further clinical development
  5. Lan Dai will detail Genentech’s approaches for process validation and comparability for post launch commercial manufacturing strategies

We look forward to welcoming you to Bad Homburg in 2015.

World ADC Frankfurt Partners

World ADC Frankfurt Exhibitors